Quadrant Biosciences Inc — Form C-AR (Regulation Crowdfunding)
Quadrant Biosciences Inc of SYRACUSE, NY filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2023-04-28.
Offering
- Filed: 2023-04-28
- Form: C-AR
- Accession: 0001644600-23-000076
Issuer
- CIK: 0001651239
- Website: quadrantbiosciences.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2015-03-13
- Address: 505 IRVING AVENUE, SYRACUSE, NY, 13210
- Employees: 126
Financials (as filed)
- Total assets (most recent): $36.3M
- Cash (most recent): $13.9M
- Revenue (most recent): $36.4M
- Revenue (prior): $60.5M
- Net income (most recent): $-2.4M
- Net income (prior): $12.2M
- Short-term debt: $8.8M
- Long-term debt: $1.9M
People (11)
| Name | Role | Location |
|---|
| Peter Cohen | Director | Miami, FL |
| James Croke | Director | Syracuse, NY |
| James Croke | General Counsel, Director | Syracuse, NY |
| Andrew Rock | Director | Belleair Bluffs, FL |
| Richard Bongo | Chief Financial Officer, Principal Accounting Officer, Director | Syracuse, NY |
| Ira Fedder | Director | Syracuse, NY |
| Richard Uhlig | CEO and Chairman | Syracuse, NY |
| Richard Uhlig | Chief Executive Officer | Syracuse, NY |
| Richard Uhlig | Chief Executive Officer, Chairman | Syracuse, NY |
| Wade West | Executive Vice President, Director | Syracuse, NY |
| Mary Ann Tyszko | Director | SYRACUSE, NY |
Reg CF filing history (6)
More